Q4 2024 Earnings Call Transcript February 4, 2025 Amgen Inc. beats earnings expectations. Reported EPS is $5.31, expectations ...

(Reuters) - Amgen posted a higher quarterly profit on Tuesday as product sales rose 11% and said late-stage studies of key ...

Amgen posted a higher quarterly profit on Tuesday, driven by an 11% rise in product sales, and said late-stage studies of key ...

Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

The drug, given by injection once monthly or less often ... Sales of cholesterol-lowering medication Repatha rose 45% to $606 million, while sales of arthritis drug Enbrel were flat at $1 billion.

We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Its fourth-quarter earnings are likely to have gained from growing product sales in Prolia, Repatha, Kyprolis ... Zacks Rank = 1 that were rebalanced monthly with zero transaction costs.

Amgen’s product sales in the fourth quarter are expected to have been driven by strong volume growth of Evenity, Repatha ... Rank = 1 that were rebalanced monthly with zero transaction costs.